Raltegravir 400mg
Raltegravir 400 mg is an antiretroviral formulation indicated for the management of HIV-1 infection. In accordance with WHO and NACO treatment guidelines, it is administered as a component of combination antiretroviral therapy (ART) to effectively suppress viral replication.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
400 mg twice daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets